Dyne Therapeutics, Inc. Shares Outstanding (Cover Page)
Dyne Therapeutics, Inc. (DYN) had Shares Outstanding (Cover Page) of 186.75 million shares as of 2026-07-24, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-29
- 2026-07-24: Entity Common Stock, Shares Outstanding 186.75M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 142.82M shares.
- 2025-07-25: Entity Common Stock, Shares Outstanding 142.26M shares.
- 2025-04-25: Entity Common Stock, Shares Outstanding 113.67M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-24 | 186.75M shares 10-Q · filed 2026-07-29 |
| 2025-10-31 | 142.82M shares 10-Q · filed 2025-11-05 |
| 2025-07-25 | 142.26M shares 10-Q · filed 2025-07-28 |
| 2025-04-25 | 113.67M shares 10-Q · filed 2025-05-08 |
| 2025-02-21 | 113.12M shares 10-K · filed 2025-02-27 |
| 2024-11-08 | 101.77M shares 10-Q · filed 2024-11-12 |
| 2024-08-09 | 100.40M shares 10-Q · filed 2024-08-12 |
| 2024-04-30 | 87.38M shares 10-Q · filed 2024-05-02 |
| 2024-02-29 | 81.96M shares 10-K · filed 2024-03-05 |
| 2023-10-27 | 61.38M shares 10-Q · filed 2023-10-30 |
| 2023-07-31 | 61.02M shares 10-Q · filed 2023-08-03 |
| 2023-04-30 | 58.31M shares 10-Q · filed 2023-05-11 |
| 2023-02-28 | 56.34M shares 10-K · filed 2023-03-02 |
| 2022-10-31 | 52.13M shares 10-Q · filed 2022-11-03 |
| 2022-07-31 | 51.77M shares 10-Q · filed 2022-08-04 |
| 2022-04-30 | 51.65M shares 10-Q · filed 2022-05-02 |
| 2022-02-28 | 51.64M shares 10-K · filed 2022-03-10 |
| 2021-10-31 | 51.53M shares 10-Q · filed 2021-11-04 |
| 2021-07-31 | 51.28M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 51.21M shares 10-Q · filed 2021-05-06 |
| 2021-02-26 | 51.46M shares 10-K · filed 2021-03-04 |
| 2020-10-31 | 45.45M shares 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |